Kwanan nan, Constp® SARS SARS-2-2 Antigen Rapp na Gwajin HSA-Products Co., LTD. (MDA) ya bada shawarar jerin lafiya, kuma yana cikin Burtaniya Sashen Lafiya kuma Ayyukan ɗan adam (DHSC) da kansa ya ƙayyade kuma karbi yabo.
Kafin wannan, Consultp® SARS na gano-cof-2 kit ɗin ganowa daga Nan Canda na Kamfanin Kasa (Cibiyar NIFDC) ce, ta hanyar tabbatar da binciken da ke cikin ƙasa, suka shiga Roguke Gidauniyar da aka ba da shawarar, Hukumar Kula da Takaddun Kiwon Lafiya ta Jamus, takaddun shaida na Kasar Sin, Takaddun Ecuadoro, Takaddun Erzil (takardar shaidar Chilil (takardar shaidar Chilil (takardar shaidar Chilil (takardar shaidar Chilil (takardar shaidar ta Brazil (takaddun shaida) , Takaddun Argentina, dominica takardar sheda, takardar shaidar Guatemala da sauran takaddun shaida. A halin yanzu, Afirka ta Kudu, Indiya, wanda ke eul, eua whereelist da sauran aikace-aikacen Takaddun shaida suna cikin ci gaba.

Tushen hoto: Ma'aikatar Lafiya ta Malaysia

HOTO: Takaddun shaida na HSA

(Tushen ITLO: Shafin Yanar Gizo na DHSC na Ma'aikatar Ma'aikatar Lafiya da Lafiya
A shekarar 2020, Ma'aikatar Lafiya da Ayyukan Kiwon lafiya da Ayyukan Jama'a a Burtaniya za su tsauta da cigaba da saurin bincike na COVID-19 sun shiga kasar don tabbatar da cewa sun isa sosai kuma abin dogaro. Akwai samfuran 120 waɗanda ke halartar tsari na tabbatarwa, wanda samfura 19 kawai suka zartar da tantancewa. Bayan watanni 6 na maimaitawa akai-akai, 200 samfurori da 1,000 mummunan samfurin da ya tabbatar da ingantaccen aikin na Nan-Products COVID na CoVID-19.

(Tushen IMAG: Hukumar Hukumar ta Jamusanci ta Jamusanci ta Jamusanci na magunguna da kuma na'urorin kiwon lafiya (Bfarmam)
Test Test Test-ID: AT593 / 21

SARKIN SARKAR-COV-2 Antigen Rapiden Gwajin Gwajin Gwaji (Ma'aikatar Gwajin Italiya)
Source: Babban shafin yanar gizon na Ma'aikatar Harkokin Kiwan lafiya na Italiya (Ganannu na Minista Hall

An yaba wa SARS-COV-2 A antigen Rapiden Rapic
Gwajin da SARS-2 na riga-2 yana da sauri, daidai, mai sauƙin aiki, kuma yana buƙatar kayan aiki da ma'aikata. Ya dace sosai ga zargin da ake zargin da ake zargi da kamuwa da cuta mai zurfi, musamman ga matsanancin cutar fashewa. Ana iya amfani dashi azaman layin farko na tsaro don kariya ta annoba, shafi gano cutar cututtukan da kuma sarrafawa, da kuma sarrafa yaduwar cutar.
COVID-19 zai kasance cikin yanayin annashuwa na dogon lokaci a nan gaba, da buƙatar gwaji zai ƙaru sosai. Don yanayin aikace-aikace daban-daban, Nanjing Liming Bio-Products Co., Ltd. ya kirkiro da gano abubuwa iri-iri + SPLIC 2 + SSAR-COV- 2 Gwajin Gwajin SARS + SARS-2 / A da B Antigen sau uku na gwajin + / A da B Evleic 2 / A da B Evleic 2 na ganowa da rigakafin a duk matakan a kasuwar duniya. A m taimaka wa yin rigakafin da kuma sarrafa cutar duniya-19 da rigakafi da rigakafin da kuma magance cututtukan numfashi kamar mura.
Lokaci: Jun-23-2021